Susquehanna International Group
CVS icon

Susquehanna International Group’s CVS Health CVS Stock Holding History

Susquehanna International Group’s Portfolio CVS Stock Details CVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$196M Sell
2,734,700
-155,300
-5% -$12M 0.02% 528
2025
Q4 		$229M Sell
2,890,000
-518,100
-15% -$40.8M 0.03% 481
2025
Q3 		$257M Sell
3,408,100
-1,991,300
-37% -$136M 0.03% 457
2025
Q2 		$372M Buy
5,399,400
+923,000
+21% +$60.5M 0.05% 280
2025
Q1 		$303M Sell
4,476,400
-2,245,600
-33% -$134M 0.05% 294
2024
Q4 		$302M Buy
6,722,000
+1,965,600
+41% +$110M 0.05% 312
2024
Q3 		$299M Buy
4,756,400
+1,059,900
+29% +$61.8M 0.05% 288
2024
Q2 		$218M Buy
3,696,500
+341,900
+10% +$21.4M 0.04% 334
2024
Q1 		$268M Buy
3,354,600
+1,108,600
+49% +$84.7M 0.05% 323
2023
Q4 		$177M Sell
2,246,000
-512,000
-19% -$36.4M 0.03% 443
2023
Q3 		$193M Sell
2,758,000
-36,200
-1% -$2.56M 0.04% 360
2023
Q2 		$193M Buy
2,794,200
+643,100
+30% +$45.8M 0.04% 354
2023
Q1 		$160M Sell
2,151,100
-55,000
-2% -$4.61M 0.03% 420
2022
Q4 		$206M Buy
2,206,100
+756,300
+52% +$73M 0.05% 325
2022
Q3 		$138M Sell
1,449,800
-342,000
-19% -$33.9M 0.04% 405
2022
Q2 		$166M Sell
1,791,800
-941,200
-34% -$91.9M 0.04% 354
2022
Q1 		$277M Sell
2,733,000
-2,254,900
-45% -$237M 0.05% 307
2021
Q4 		$515M Sell
4,987,900
-1,084,700
-18% -$100M 0.08% 195
2021
Q3 		$515M Buy
6,072,600
+251,700
+4% +$21.1M 0.07% 232
2021
Q2 		$486M Sell
5,820,900
-864,300
-13% -$70.8M 0.07% 231
2021
Q1 		$503M Buy
6,685,200
+797,500
+14% +$58.1M 0.08% 200
2020
Q4 		$402M Sell
5,887,700
-523,400
-8% -$34M 0.07% 221
2020
Q3 		$374M Buy
6,411,100
+2,337,300
+57% +$145M 0.07% 197
2020
Q2 		$265M Buy
4,073,800
+221,000
+6% +$13.9M 0.06% 247
2020
Q1 		$229M Buy
3,852,800
+256,700
+7% +$17.1M 0.07% 205
2019
Q4 		$267M Sell
3,596,100
-1,804,800
-33% -$127M 0.08% 208
2019
Q3 		$341M Sell
5,400,900
-2,926,100
-35% -$173M 0.11% 146
2019
Q2 		$454M Buy
8,327,000
+1,491,900
+22% +$80.3M 0.16% 86
2019
Q1 		$369M Buy
6,835,100
+4,337,100
+174% +$268M 0.15% 105
2018
Q4 		$164M Sell
2,498,000
-428,200
-15% -$32M 0.07% 264
2018
Q3 		$230M Sell
2,926,200
-91,900
-3% -$6.57M 0.08% 216
2018
Q2 		$194M Buy
3,018,100
+751,500
+33% +$49.5M 0.07% 250
2018
Q1 		$141M Sell
2,266,600
-1,250,800
-36% -$89.7M 0.05% 293
2017
Q4 		$255M Buy
3,517,400
+2,408,000
+217% +$175M 0.09% 195
2017
Q3 		$90.2M Sell
1,109,400
-211,900
-16% -$16.8M 0.03% 421
2017
Q2 		$106M Sell
1,321,300
-1,457,100
-52% -$115M 0.05% 334
2017
Q1 		$218M Buy
2,778,400
+1,739,800
+168% +$139M 0.11% 155
2016
Q4 		$82M Buy
1,038,600
+313,900
+43% +$25.4M 0.04% 387
2016
Q3 		$64.5M Buy
724,700
+270,300
+59% +$25.5M 0.03% 449
2016
Q2 		$43.5M Buy
454,400
+8,300
+2% +$827K 0.02% 565
2016
Q1 		$46.3M Sell
446,100
-740,600
-62% -$72M 0.02% 550
2015
Q4 		$116M Sell
1,186,700
-155,500
-12% -$15.2M 0.05% 312
2015
Q3 		$129M Buy
1,342,200
+854,100
+175% +$89.8M 0.06% 299
2015
Q2 		$51.2M Buy
488,100
+207,000
+74% +$21.1M 0.02% 679
2015
Q1 		$29M Sell
281,100
-196,700
-41% -$19.9M 0.01% 964
2014
Q4 		$46M Sell
477,800
-78,700
-14% -$6.93M 0.02% 767
2014
Q3 		$44.3M Buy
556,500
+358,000
+180% +$28.2M 0.02% 814
2014
Q2 		$15M Sell
198,500
-237,600
-54% -$18M 0.01% 1669
2014
Q1 		$32.6M Sell
436,100
-563,400
-56% -$39.8M 0.02% 884
2013
Q4 		$71.5M Sell
999,500
-29,700
-3% -$1.91M 0.03% 489
2013
Q3 		$58.4M Buy
1,029,200
+181,900
+21% +$10.8M 0.03% 529
2013
Q2 		$48.4M Buy
+847,300
New +$49.1M 0.03% 573

Other funds holding CVS

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Susquehanna International Group's CVS Position: Q1 2026 in Review

Susquehanna International Group reduced its CVS Health (CVS) stake by 74% in Q1 2026, selling an estimated $87.3M and leaving 393,977 shares worth $28.3M. The position accounts for ﹤0.01% of the portfolio, ranked #1803.

Susquehanna International Group first reported a position in CVS in Q2 2013 and has held it in 50 quarters since. The position peaked at $306M in Q2 2019. 1,866 funds tracked by Wall St. Rank hold CVS as of Q1 2026.

  • Susquehanna International Group held 393,977 shares of CVS Health worth $28.3M as of Q1 2026.
  • Susquehanna International Group sold 1,132,833 CVS Health shares in Q1 2026, an estimated $87.3M.
  • CVS Health made up ﹤0.01% of Susquehanna International Group's portfolio in Q1 2026, its #1803 holding.
  • Susquehanna International Group first reported a position in CVS Health in Q2 2013 and has held it in 50 quarters since.
  • Susquehanna International Group's CVS Health position peaked at $306M in Q2 2019.
  • 1,866 funds tracked by Wall St. Rank held CVS Health as of Q1 2026.

Based on Susquehanna International Group's 13F filing for Q1 2026, filed 15 May 2026.